Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-04-04 Sale | 2019-05-02 2:08 pm | NEXIEN BIOPHARMA INC. | NXEN | Kanativa Inc. 10% Owner | 5,000,000 | $0.085 | $425,000 | 19,000,000 (Indirect) | View |
| 2019-04-04 Sale | 2019-05-01 7:56 pm | NEXIEN BIOPHARMA INC. | NXEN | Friedland Jeffrey Former 10% Owner | 5,000,000 | $0.085 | $425,000 | 20,062,133 (Indirect Direct) | View |
| 2019-04-04 Sale | 2019-05-01 7:15 pm | NEXIEN BIOPHARMA INC. | NXEN | Kanativa USA Inc. 10% Owner | 5,000,000 | $0.085 | $425,000 | 19,000,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-08-19 Option Award | 2023-08-03 10:23 am | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Goldfarb Robert I Chief Operating Officer | 1,500,000 | $0 | 3,278,000 (Direct) | View |
| 2023-07-25 Option Award | 2023-07-31 5:41 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 250,000 | $0 | 11,914,052 (Direct) | View |
| 2023-07-25 Option Award | 2023-07-31 3:35 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 250,000 | $0 | 6,370,000 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-19 6:48 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 250,000 | $0 | 6,120,000 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-19 4:16 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 250,000 | $0 | 11,664,052 (Direct) | View |
| 2020-08-19 Option Award | 2023-01-18 5:42 pm | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Goldfarb Robert I Chief Operating Officer | 1,250,000 | $0 | 2,778,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 1:27 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 250,000 | $0 | 11,414,052 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 1:23 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 250,000 | $0 | 5,870,000 (Direct) | View |
| 2020-08-19 Option Award | 2022-10-18 12:45 pm | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Goldfarb Robert I Chief Operating Officer | 1,250,000 | $0 | 2,528,800 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-18 11:07 am | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 250,000 | $0 | 11,164,052 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-18 11:04 am | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 250,000 | $0 | 5,620,000 (Direct) | View |
| 2022-04-20 Option Award | 2022-09-15 4:06 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 500,000 | $0 | 10,914,052 (Direct) | View |
| 2020-08-19 Option Award | 2022-09-14 5:45 pm | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Goldfarb Robert I Chief Operating Officer | 1,250,000 | $0 | 2,278,800 (Direct) | View |
| 2022-04-20 Option Award | 2022-09-14 5:42 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 500,000 | $0 | 5,370,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 3:56 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 250,000 | $0 | 10,414,051 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 3:55 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 250,000 | $0 | 4,870,000 (Direct) | View |
| 2021-11-29 Option Award | 2021-11-29 12:23 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 500,000 | $0 | 10,164,051 (Direct) | View |
| 2021-11-29 Option Award | 2021-11-29 12:20 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 500,000 | $0 | 4,620,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-07 6:00 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Snider Lindy Director | 250,000 | $0 | 830,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 5:34 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 1,000,000 | $0 | 4,120,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 5:33 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 1,000,000 | $0 | 9,664,051 (Direct) | View |
| 2020-11-24 Option Award | 2020-11-30 3:58 pm | 2020-11-24 2023-11-24 | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer 10% Owner | 3,228,859 | $0 | 8,664,051 (Direct) | View |
| 2020-08-12 Conversion(A) | 2020-08-25 5:19 pm | N/A N/A | NEXIEN BIOPHARMA INC. | KDRH | Greenberg Richard S Chief Executive Officer | 1,797,192 | $0.014 | 5,435,192 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 1:17 pm | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer | 2,500,000 | $0 | 5,708,880 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 1:16 pm | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 1,500,000 | $0 | 3,120,000 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 1:15 pm | 2020-08-19 2027-08-19 | NEXIEN BIOPHARMA INC. | NXEN | Goldfarb Robert I Chief Operating Officer | 1,000,000 | $0 | 2,028,800 (Direct) | View |
| 2020-08-12 Conversion | 2020-08-14 5:33 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S Chief Executive Officer | 1,800,880 | $0.014 | 2,938,880 (Direct) | View |
| 2019-11-22 Gift | 2019-11-25 2:07 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Friedland Jeffrey Former 10% Owner | 1,062,133 | $0 | 19,000,000 (Direct) | View |
Ownership | 2019-05-02 2:07 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Kanativa Inc. 10% Owner | 0 | $0 | 24,000,000 (Indirect) | View |
Ownership | 2018-11-08 3:29 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Manganella Frank J VP Corporate Development | 0 | $0 | 2,420,000 (Direct) | View |
Ownership | 2018-11-02 5:18 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Reeh Jeremy Robert VP Translational Research | 0 | $0 | 1,925,000 (Direct) | View |
Ownership | 2018-11-01 4:22 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Wasyl Alexander Michael Chief Executive Officer | 0 | $0 | 5,445,000 (Direct) | View |
Ownership | 2018-10-31 5:19 pm | N/A N/A | NEXIEN BIOPHARMA INC. | NXEN | Aceto Joseph F VP Legal & IP Counsel | 0 | $0 | 1,045,000 (Direct) | View |
| 2018-10-26 Option Award | 2018-10-30 1:59 pm | 2018-10-26 2025-10-26 | NEXIEN BIOPHARMA INC. | NXEN | Wasoff Evan L Chief Financial Officer | 200,000 | $0 | 1,620,000 (Direct) | View |
| 2018-10-01 Option Award | 2018-10-29 6:35 pm | 2018-10-01 2025-10-01 | NEXIEN BIOPHARMA INC. | NXEN | Bankier Alain D Executive Chairman | 1,000,000 | $0 | 4,224,000 (Direct) | View |
| 2018-10-26 Option Award | 2018-10-29 3:04 pm | 2018-10-26 2025-10-26 | NEXIEN BIOPHARMA INC. | NXEN | Greenberg Richard S EVP | 100,000 | $0 | 1,138,000 (Direct) | View |